Navigation Links
SURGIWIPtrade; Suture Ligature with SURGIDACtrade;

ProductsSURGIWIPtrade; Suture Ligature with SURGIDACtrade;
Company Autosuture
Item SURGIWIPtrade; Suture Ligature with SURGIDACtrade;
Features 
  • V-20 or SK taper
  • Single use
  • With SURGIDAC™
  • Size 0 USP (3.5 Metric), Size 2-0 USP (3 Metric)
  • 48 inches (120 cm) length
  • GREEN Coated, Braided, Polyester Suture
  • 12 units per box
    • Description The SURGIWIP™ suture ligature with delivery system is indicated for use in gynecologic, general and other abdominal and thoracic endoscopic procedures where a suture is appropriate for the endoscopic approximation and ligation of soft tissues.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. SURGIWIPtrade; Suture Ligature with POLYSORBtrade;
    2. Serdarevic Suture Hook
    3. Castroviejo Suture Forceps
    4. OGawa Straight Suture-Fixation Forceps - 0.12 mm
    5. Colibri Suture Removal Forceps
    6. Paton Extra Delicate Suture Forceps
    7. Suture tying forceps
    8. Suture Removal Forceps #5a
    9. Micro Suture Forceps
    10. Suture Forceps
    11. Shutt® Suture Punch System
    Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 1COMFORCE Corporation to Hold Conference Call to Discuss Second Quarter 2009 Results 53484 2Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 1Therapy Technique Cuts Divorce Separation Rate By Nearly 50 Percent 53482 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 1Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 2Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 3Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab 13330 4